|
FUNDC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.281530E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.258230E-02 |
| Normal-vs-Stage2 |
8.386000E-01 |
| Normal-vs-Stage3 |
2.138400E-03 |
| Normal-vs-Stage4 |
2.80199999869168E-08 |
| Stage1-vs-Stage2 |
1.201210E-01 |
| Stage1-vs-Stage3 |
2.297200E-01 |
| Stage1-vs-Stage4 |
3.81489999999873E-05 |
| Stage2-vs-Stage3 |
2.874300E-02 |
| Stage2-vs-Stage4 |
3.6333000000055E-05 |
| Stage3-vs-Stage4 |
7.955400E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.982800E-04 |
| Normal-vs-AfricanAmerican |
2.116800E-01 |
| Normal-vs-Asian |
1.994170E-01 |
| Caucasian-vs-AfricanAmerican |
5.971600E-01 |
| Caucasian-vs-Asian |
3.427600E-01 |
| AfricanAmerican-vs-Asian |
8.741000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.67073038631816E-12 |
| Normal-vs-Female |
1.417190E-01 |
| Male-vs-Female |
9.65894031423886E-15 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.042400E-03 |
| Normal-vs-Age(41-60Yrs) |
8.655100E-03 |
| Normal-vs-Age(61-80Yrs) |
2.702000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.032050E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.728000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.575200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.582600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.254800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.102800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.686200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.250480E-02 |
| Classical-VS-Follicular |
1.141610E-03 |
| Classical-VS-Other |
4.979800E-01 |
| Classical-VS-Normal |
1.276480E-03 |
| Tall-VS-Follicular |
2.27500000005154E-06 |
| Tall-VS-Other |
4.794600E-01 |
| Tall-VS-Normal |
1.78660000005326E-06 |
| Follicular-VS-Other |
1.672350E-02 |
| Follicular-VS-Normal |
6.178600E-01 |
| Other-VS-Normal |
2.793700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.384400E-02 |
| Normal-vs-N1 |
3.243600E-02 |
| N0-vs-N1 |
3.228600E-01 |
|
|
